Human Papillomavirus Infection by Number of Vaccine Doses Among US Women
This cross-sectional study investigates the prevalence of human papillomavirus (HPV) infection among US women who received between 0 and 3 doses of HPV vaccine.
Related Articles
Phacogoniotomy vs Phacotrabeculectomy in Advanced PACG With Cataract
This secondary analysis of the Phacogoniotomy vs Phacotrabeculectomy (PVP) randomized clinical trial investigates if intraocular pressure reduction with phacogoniotomy is noninferior to phacotrabeculectomy in advanced…
Value-Based State-Directed Payments in Medicaid Managed Care
This cross-sectional study examined the scale and scope of value-based state-directed payments in Medicaid managed care.
Patient Information: Typhoid Fever
This JAMA Patient Page describes typhoid fever and its symptoms, vaccination options, and disease risk reduction measures.
Negative Effects During Placebo Treatment
This study compares premature study termination rates in placebo groups of high-quality randomized clinical trials across 9 major psychiatric disorders, focusing on total dropouts, dropouts…
Dasatinib and CAR T-Cell Therapy in Newly Diagnosed Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia
This nonrandomized clinical trial examines the efficacy and safety of dasatinib in combination with chimeric antigen receptor T cells as frontline therapy in adults with…
Finerenone for Heart Failure and Risk Estimated by the PREDICT-HFpEF Model
This randomized clinical trial evaluated the effectiveness of finerenone in patients with heart failure and mildly reduced ejection fraction or preserved ejection fraction across the…
Reducing Inhaler-Related Greenhouse Gas Emissions
This Perspective examines how transitioning from metered-dose inhalers to dry-powder and soft-mist inhalers could reduce inhaler-related emissions, thereby moderating inhalers’ contribution to climate change.
Area Deprivation Index and Melanoma Thickness in Veterans
This cohort study evaluates if neighborhood deprivation is associated with thicker (greater than 2 mm) cutaneous melanoma diagnosis after controlling for individual-level characteristics in the…
Outcomes in Transplant Recipients With Advanced Cancers Receiving Immune Checkpoint Inhibitors
This systematic review and individual participant data met-analysis assesses the cancer-related and survival outcomes in solid organ transplant recipients with advanced-stage cancer treated with immune…
Zongertinib in Previously Treated HER2-Mutant Non–Small-Cell Lung Cancer | NEJM
Innovative oral targeted therapies are warranted for patients with human epidermal growth factor receptor 2 (HER2)–mutant non–small-cell lung cancer (NSCLC). Zongertinib is an oral, irreversible,…